Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.
Yu T, Chaganty B, Lin L, Xing L, Ramakrishnan B, Wen K, Hsieh PA, Wollacott A, Viswanathan K, Adari H, Cho SF, Li Y, Chen H, Yang W, Xu Y, An G, Qiu L, Munshi N, Babcock G, Shriver Z, Myette JR, Anderson KC, Tai YT. Yu T, et al. Among authors: adari h. Blood Cancer J. 2020 Nov 2;10(11):110. doi: 10.1038/s41408-020-00378-z. Blood Cancer J. 2020. PMID: 33149123 Free PMC article.
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules.
Rittershaus CW, Thomas LJ, Miller DP, Picard MD, Geoghegan-Barek KM, Scesney SM, Henry LD, Sen AC, Bertino AM, Hannig G, Adari H, Mealey RA, Gosselin ML, Couto M, Hayman EG, Levin JL, Reinhold VN, Marsh HC Jr. Rittershaus CW, et al. Among authors: adari h. J Biol Chem. 1999 Apr 16;274(16):11237-44. doi: 10.1074/jbc.274.16.11237. J Biol Chem. 1999. PMID: 10196211 Free article.
15 results